M. Brooke Bernhardt, Pharm.D., M.S., FCCP
Picture
Positions
- Assistant Professor
-
Pediatrics
Hematology/Oncology
Baylor College Medicine
Houston, Texas United States
- Director of Pharmacy
-
Texas Children's Global HOPE (Hematology/Oncology Pediatric Excellence)
Education
- PharmD from University of Georgia
- 05/2003 - Athens, Georgia United States
- MS from University of Houston
- 05/2013 - Houston, Texas United States
- Residency at University of Virginia
- 07/2005 - Charlottesville, Virginia United States
- Residency at University of Alabama - Birmingham
- 07/2004 - Birmingham, Alabama United States
Certifications
- Board Certified Oncology Pharmacist
- Board of Pharmaceutical Specialties
- Board Certified Pediatric Pharmacist
- Board of Pharmaceutical Specialties
Professional Interests
- Pharmacogenomics
- Treatment-related toxicity
- Childhood cancer
- Pharmacokinetics
Websites
Selected Publications
- Russell HV, Chi YY, Okcu MF, Bernhardt MB, Rodriguez-Galindo C, Gupta AA, Hawkins DS. "Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group." Cancer. 2022 Jan 15;128(2) Pubmed PMID: 34623638
- Schraw JM, Woodhouse JP, Bernhardt MB, Taylor OA, Horton TM, Scheurer ME, Okcu MF, Rabin KR, Lupo PJ, Brown AL. "Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia." Sci Rep.. 2021 Oct 4;11(1) Pubmed PMID: 34608220
- Zobeck MC, Bernhardt MB, Kamdar KY, Rabin KR, Lupo PJ, Scheurer ME. "Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene." Pediatr Blood Cancer. 2021 Aug;68(8) Pubmed PMID: 33788417
- Kirk SE, Scheurer ME, Bernhardt MB, Mahoney DH, Powers JM. "Phosphorus levels in children treated with intravenous ferric carboxymaltose." Am J Hematol. 2021 Jun 1;96(6) Pubmed PMID: 33735470
- Brown PA, Ji L, Xu X, Devidas M, Hogan LE, Borowitz MJ, Raetz EA, Zugmaier G, Sharon E, Bernhardt MB, Terezakis SA, Gore L, Whitlock JA, Pulsipher MA, Hunger SP, Loh ML. "Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial." JAMA. 2021 Mar 2;325(9) Pubmed PMID: 33651090
- McAtee CL, Lubega J, Underbrink K, Curry K, Msaouel P, Barrow M, Muscal E, Lotze T, Srivaths P, Forbes LR, Allen C, Bernhardt MB. "Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults." JAMA Netw Open. 2021 Feb 1;4(2) Pubmed PMID: 33533931
- Bernhardt MB, Lindsay H, Allen-Rhoades W, Foster JH. "The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority-An oncology perspective." Pediatr Blood Cancer. 2021 Mar;68(3) Pubmed PMID: 33381908
- Bernhardt MB, Militano O, Honeyford L, Zupanec S. "Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challenges." J Oncol Pharm Pract. 2021 Mar 27;2 Pubmed PMID: 33334253
- Brown AL, Raghubar KP, Taylor OA, Bernhardt MB, Kahalley LS, Pan W, Lupo PJ, Hockenberry MJ, Scheurer ME. "Prospective patient-reported symptom profiles associated with pediatric acute lymphoblastic leukemia relapse." Support Care Cancer. 2021 May;29(5) Pubmed PMID: 32929538
- Brown AL, Sok P, Taylor O, Woodhouse JP, Bernhardt MB, Raghubar KP, Kahalley LS, Lupo PJ, Hockenberry MJ, Scheurer ME. "Cerebrospinal Fluid Metabolomic Profiles Associated With Fatigue During Treatment for Pediatric Acute Lymphoblastic Leukemia." J Pain Symptom Manage. 2021 Mar;61(3) Pubmed PMID: 32889041
Memberships
- Children's Oncology Group
- American College of Clinical Pharmacy
- American Society of Health-System Pharmacy
- International Society of Oncology Pharmacy Practitioners
- International Society of Paediatric Oncology
Log In to edit your profile
